House China panel probes Bristol Myers, Pfizer over clinical trial sites tied to the Chinese military and Xinjiang amid scrutiny of pharma's China ties.

House China panel probes Bristol Myers, Pfizer over clinical trial sites tied to the Chinese military and Xinjiang amid scrutiny of pharma's China ties.

The U.S. House Select Committee on China has opened investigations into five pharmaceutical companies regarding their clinical trials in China, questioning whether the drugmakers…